scholarly journals Effect of omega-3 fatty acid on contrast-induced nephropathy

2021 ◽  
pp. 15-25
Author(s):  
Gunes Bolatli ◽  
Mahinur Ulusoy ◽  
Fatih Tas ◽  
Naci Omer Alayunt ◽  
Ismail Zarasiz
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Kidney Tissue ◽  
High Morbidity ◽  
Therapeutic Effects ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Contrast Induced Nephropathy ◽  
Omega 3 Fatty Acid ◽  
Iodinated Contrast

Abstract. Renal failure that develops acutely after the use of iodinated contrast material is called "contrast-induced nephropathy". It is a complication with high morbidity and mortality risk. Current treatments are aimed at protecting kidney functions, new treatment methods are being researched. This study aims to demonstrate the therapeutic effects of omega-3 fatty acids on CIN, taking into account the possible clinical usage of iodinated contrast media and the benefits of omega-3 fatty acids. Methods. A total of 30 rats were studied, divided into four groups. Only saline was administered by gavage to group 1, only IV urography to group 2, only 400 mg omega-3 to group 3, and urography and 400 mg omega-3 to group 4. At the end of the study, kidney tissue and serum oxidative and antioxidant markers, and creatinine levels were analyzed. Result. While the degrees of glutathione peroxidase, catalase and total antioxidant capacity in kidney tissue and serum tests of rats treated with omega-3 fatty acid increased statistically; total oxidant capacity and malondialdehyde levels were found to be significantly lower. Furthermore, blood urea nitrogen and creatinine levels were found to be significantly lower in the omega-3 treated group. Conclusion. Omega-3 fatty acids had therapeutic effects in the experimental CIN model. As a result, we believe omega-3 fatty acids can be used as an alternative to existing supportive medicines in this common disease with few therapy options.

Omega-3 Levels and Nicotine Dependence: A Cross-Sectional Study and Clinical Trial

2015 ◽  
Vol 22 (3) ◽  
pp. 153-162 ◽  
Author(s):  
Juçara X. Zaparoli ◽  
Eduardo K. Sugawara ◽  
Altay A.L. de Souza ◽  
Sérgio Tufik ◽  
José Carlos F. Galduróz
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Fish Oil ◽  
Nicotine Dependence ◽  
Cross Sectional Study ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Double Blind ◽  
Cross Sectional ◽  
Omega 3 Fatty Acid

Background: High oxidative stress, which is caused by smoking, can alter omega-3 fatty acid concentrations. Since omega-3 fatty acids play a role in dopaminergic neurotransmission related to dependence, it is important to understand their effects on nicotine dependence. Methods: This research comprised 2 studies. The first one consisted of a cross-sectional evaluation, in which the levels of the most important omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), were compared between smokers and non-smokers in a sample of 171 individuals; of them, 120 were smokers and 51 were non-smokers. The other study was a clinical, double-blind, randomized, placebo controlled, in which 63 smokers received daily treatment with capsules of fish oil (a source of omega-3/3 g/day) or mineral oil (used as placebo, also 3 g/day), taken 3 times a day for 90 days. Each fish oil capsules contained approximately 210.99 mg EPA and 129.84 mg of DHA. The outcome was evaluated by means of psychometric and biological measures as well as self-reports of tobacco use. The evaluations were carried out at the beginning of treatment and once a month thereafter (total of 4 times). Outcomes: The omega-3 fatty acid lipid profile showed that smokers present lower concentrations of DHA. After treatment, the omega-3 group showed a significant reduction in their levels of dependence. Interpretation: Smokers showed lower peripheral levels of omega-3, and treatment with the most important omega-3 fatty acids brought about a reduction in nicotine dependence.

scholarly journals The combined supplementation of omega-3 fatty acids and probiotics decreased the levels of serum polyamines in experimental colitis

2021 ◽  
Vol 7 (4) ◽  
pp. 279-285
Author(s):  
Havvanur Yoldaş İlktaç ◽  
Nihal Büyükuslu ◽  
Cüneyd Parlayan
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
High Performance ◽  
Experimental Colitis ◽  
Serum Levels ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Lower Serum ◽  
Omega 3 Fatty Acid ◽  
Combined Supplementation

Polyamines play an important role in the maintenance of intestinal permeability. Therefore we aimed to determine the effects of probiotics and omega 3 fatty acids on serum polyamine levels in colitis. Fifty BALB/c mice were randomly grouped as normal, colitis with no treatment applied, colitis treated by probiotics (VSL#3), colitis treated by omega-3, and colitis treated by both probiotics and omega-3. Experimental colitis was induced by injection of 200 mg/kg 2,4-Dinitrobenzenesulfonic acid (DNBS). The probiotic and the omega-3 fatty acid supplements were applied daily by oral gavage. Serum polyamine levels were measured with high performance liquid chromatography (HPLC). In each group, the levels of serum polyamines are the highest in spermidine and the least in spermine. Bowel inflammation in experimentally induced colitis mice resulted in lower serum polyamine concentrations. In probiotic and omega 3 fatty acid supplemented group significant decreases were observed for spermine and spermidine (p<0.001), while no significant changes were obtained for putrescine. Combined supplementation of probiotics and omega-3 fatty acids for 10 days in colitis mice significantly decreased the serum levels of spermine and spermidine.

Abstract 168: Impact of Continuing Medical Education on the Treatment of Hypertriglyceridemia with Omega-3 Fatty Acids

2016 ◽  
Vol 9 (suppl_2) ◽  
Author(s):  
Amy Larkin ◽  
Michael LaCouture ◽  
George Boutsalis ◽  
Harold Bays
Keyword(s):  
Fatty Acids ◽  
Medical Education ◽  
Fatty Acid ◽  
Online Education ◽  
Continuing Medical Education ◽  
Primary Care Physicians ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Omega 3 Fatty Acid

Introduction: The less prominent role of triglycerides in determining cardiovascular risk keeps these lipids from being top-of-mind for practicing clinicians, yet epidemiologic data affirm that hypertriglyceridemia contributes to atherosclerotic disease development and progression. We sought to determine if online continuing medical education (CME) could improve the clinical knowledge and competence of primary care physicians (PCPs) and cardiologists regarding hypertriglyceridemia and the use of omega-3 fatty acids in its treatment. Methods: The effects of two educational interventions about advances in hypertriglyceridemia treatment (activity 1) and educating patients about omega-3 fatty acid products (activity 2) were analyzed to determine efficacy of online education presented in the form of online video-based roundtable discussions. The activities launched online in May and June, 2015 respectively, and data were collected through July, 2015. The effects of education were assessed using knowledge- and case-based matched pre-assessment/post-assessments. The effect sizes were calculated with Cohen’s d (> 0.8 is large, 0.8-0.4 is medium, and < 0.4 is small). Results: In total, 842 PCPs and 75 cardiologists who completed all pre/post assessment questions in any of the two activities during the study period were included in analyses. Significant overall improvements were seen for PCPs (activity 1: n = 452, P <.05, effect d= 0.68; activity 2: n = 390, P <.05, effect d= 0.96) and cardiologists (activity 1: n = 35, P <.05, effect d= 0.77; activity 2: n = 40, P <.05, effect d= 0.9). Compared with baseline, specific areas of improvements include: • 22% more PCPs and 31% more cardiologists identified weight loss as a nonpharmacological intervention that can effectively lower triglyceride levels for overweight/obese patients with hypertriglyceridemia, (both P < .05) • 35% more PCPs and 32% more cardiologists identified the appropriate dosing of prescription omega-3 fatty acids (both P <.05) • 23% more PCPs ( P < .05) and 20% more cardiologists ( P =.068 ) recognized that reducing the risk for pancreatitis is a primary medical objective in patients with severe elevations in triglyceride levels Areas identified as needing additional education include: • 57% of all physicians remain unaware that omega-3 fatty acids reduce apolipoprotein C3 • 61% of PCPs and 60% of cardiologists did not demonstrate a thorough understanding of the differences between prescription omega-3 fatty acids and omega-3 supplements Conclusion: This study demonstrates the success of a targeted educational intervention with two educational components on improving knowledge, competence, and clinical decision-making of PCPs and cardiologists regarding hypertriglyceridemia treatment and the role of omega-3 fatty acid products in its treatment.

scholarly journals Identification of Novel Acinetobacter baumannii Host Fatty Acid Stress Adaptation Strategies

mBio ◽  
2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Jhih-Hang Jiang ◽  
Karl A. Hassan ◽  
Stephanie L. Begg ◽  
Thusitha W. T. Rupasinghe ◽  
Varsha Naidu ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Acinetobacter Baumannii ◽  
Bacterial Membrane ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Efflux System ◽  
Content Type ◽  
Omega 3 Fatty Acid ◽  
Omega 6

ABSTRACT Free fatty acids hold important immune-modulatory roles during infection. However, the host’s long-chain polyunsaturated fatty acids, not commonly found in the membranes of bacterial pathogens, also have significant broad-spectrum antibacterial potential. Of these, the omega-6 fatty acid arachidonic acid (AA) and the omega-3 fatty acid decosahexaenoic acid (DHA) are highly abundant; hence, we investigated their effects on the multidrug-resistant human pathogen Acinetobacter baumannii. Our analyses reveal that AA and DHA incorporate into the A. baumannii bacterial membrane and impact bacterial fitness and membrane integrity, with DHA having a more pronounced effect. Through transcriptional profiling and mutant analyses, we show that the A. baumannii β-oxidation pathway plays a protective role against AA and DHA, by limiting their incorporation into the phospholipids of the bacterial membrane. Furthermore, our study identified a second bacterial membrane protection system mediated by the AdeIJK efflux system, which modulates the lipid content of the membrane via direct efflux of lipids other than AA and DHA, thereby providing a novel function for this major efflux system in A. baumannii. This is the first study to examine the antimicrobial effects of host fatty acids on A. baumannii and highlights the potential of AA and DHA to protect against A. baumannii infections. IMPORTANCE A shift in the Western diet since the industrial revolution has resulted in a dramatic increase in the consumption of omega-6 fatty acids, with a concurrent decrease in the consumption of omega-3 fatty acids. This decrease in omega-3 fatty acid consumption has been associated with significant disease burden, including increased susceptibility to infectious diseases. Here we provide evidence that DHA, an omega-3 fatty acid, has superior antimicrobial effects upon the highly drug-resistant pathogen Acinetobacter baumannii, thereby providing insights into one of the potential health benefits of omega-3 fatty acids. The identification and characterization of two novel bacterial membrane protective mechanisms against host fatty acids provide important insights into A. baumannii adaptation during disease. Furthermore, we describe a novel role for the major multidrug efflux system AdeIJK in A. baumannii membrane maintenance and lipid transport. This core function, beyond drug efflux, increases the appeal of AdeIJK as a therapeutic target.

From Homicide to Happiness – A Commentary on Omega-3 Fatty Acids in Human Society

2007 ◽  
Vol 19 (1-2) ◽  
pp. 9-19 ◽  
Author(s):  
Joseph R. Hibbeln
Keyword(s):  
Risk Factors ◽  
Fatty Acids ◽  
Fatty Acid ◽  
American Psychiatric Association ◽  
Human Society ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Omega 3 Fatty Acid ◽  
Increased Risk ◽  
Omega 6

The field of omega-3 fatty acid deficiencies as reversible risk factors in major psychiatric disorders has flourished in the last decade. Treatment recommendations of the American Psychiatric Association may be considered for application to more normative states of psychiatric health. Considered here is the proposition that an increased risk of personality disorders, and an increased sense of despair in normative populations, might be considered as symptoms of deficiencies of omega-3 fatty acids. The major changes in the essential fatty acid composition of the food supply, including increased availability of the omega-6 linoleic acid, may be correlated not only with increased risks of homicide, but also increased risks of suicide and suboptimal social cohesion.

scholarly journals Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
William S. Harris ◽  
◽  
Nathan L. Tintle ◽  
Fumiaki Imamura ◽  
Frank Qian ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
De Novo ◽  
Premature Death ◽  
Pooled Analysis ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Alpha Linolenic Acid ◽  
Omega 3 Fatty Acid

AbstractThe health effects of omega-3 fatty acids have been controversial. Here we report the results of a de novo pooled analysis conducted with data from 17 prospective cohort studies examining the associations between blood omega-3 fatty acid levels and risk for all-cause mortality. Over a median of 16 years of follow-up, 15,720 deaths occurred among 42,466 individuals. We found that, after multivariable adjustment for relevant risk factors, risk for death from all causes was significantly lower (by 15–18%, at least p < 0.003) in the highest vs the lowest quintile for circulating long chain (20–22 carbon) omega-3 fatty acids (eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids). Similar relationships were seen for death from cardiovascular disease, cancer and other causes. No associations were seen with the 18-carbon omega-3, alpha-linolenic acid. These findings suggest that higher circulating levels of marine n-3 PUFA are associated with a lower risk of premature death.

scholarly journals Omega 3 Fatty Acid Consumption from Seafood and Cognitive Functioning, 2011-2014 (P18-085-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Samara Joy Nielsen
Keyword(s):  
Fatty Acids ◽  
Fatty Acid ◽  
Digit Symbol Substitution Test ◽  
Digit Symbol ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Omega 3 Fatty Acid ◽  
Acid Consumption ◽  
Symbol Substitution ◽  
Fluency Test

Abstract Objectives To examine the relationship between omega 3 fatty acid consumption from seafood and cognitive functioning. Methods Using NHANES data from 2011–2014, examine 60–80 year olds cognitive function. Three different assessments will be used for analysis: the CERAD Word Learning subtest, the Animal Fluency test and the Digit Symbol Substitution test. Seafood consumption in the past 30 days was used to calculate estimated omega 3 consumption per day. Omega 3 consumption was categorized into 3 categories: zero consumption; 0 < omega 3 consumption < 250 mg and omega 3 consumption ≥ 250 mg. Results Cognitive function was positively associated with omega 3 consumption. Those who did not consume omega 3 fatty acids from seafood were at greater risk of cognitive decline. In comparison with people who consumed ≥ 250 mg of omega 3 fatty acids per day, those who consumed no omega 3 fatty acids from seafood were 2.26 (1.52, 3.38) times more likely to score lower on the CERAD Word Learning subtest. Similarly, in comparison with people who consumed ≥ 250 mg of omega 3 fatty acids per day, those who consumed no omega 3 fatty acids from seafood were 1.88 (1.27, 2.79) times more likely to score lower on the Animal Fluency test. In addition, in comparison with people who consumed ≥ 250 mg of omega 3 fatty acids per day, those who consumed no omega 3 fatty acids from seafood were almost 3 times more likely (2.99 (1.98, 4.51) to score lower on the Digit Symbol Substitution test. Conclusions Consuming ≥ 250 mg per day of omega 3 fatty acids from seafood may help prevent cognitive decline. Funding Sources No funding received.

Sign in / Sign up

Export Citation Format

Share Document